Currency rates from 24/09/2024
$1 – 12747.29
UZS – 0.14%
€1 – 14158.42
UZS – -0.35%
₽1 – 137.27
UZS – -0.14%
Search
Economy 19/12/2008 GM Powertrain Uzbekistan to produce engines for car industry
GM Powertrain Uzbekistan to produce engines for car industry
Tashkent, Uzbekistan (UzDaily.com) -- US giant General Motors and Uzavtosanoat, a state run company, which unites enterprises of car industry of Uzbekistan, founded a new joint venture General Motors Powertrain Uzbekistan to produce car engines for GM Uzbekistan, Uzbek carmaker.

GM Uzbekistan is venture between General Motors and Uzavtosanoat, which produces vehicles in Asaka, Andijan region of Uzbekistan.

Construction of the plant of GM Powertrain Uzbekistan started in Tashkent region and it will produce 360,000 engines a year. It is expected that the venture will start its work on 30 March 2011.

The joint venture will produce engines with volume of 1, 1.2, 1.4 and 1.5 litters.

Uzavtosanoat and South Korea’s Daewoo Motor created a joint venture - UzDaewoo Auto - on parity conditions with the charter capital of US$200 million. In 1996, the venture launched car production plant with the cost of US$650 million in Asaka city of Andijan region. The capacity of the venture is 200,000 cars per year.

In May 2005, Uzavtosanoat purchased 50% shares of Daewoo Motor in UzDaewoo Auto for about US$110 million.

General Motors and Uzavtoprom completed process of creation of GM Uzbekistan on the base of UzDaewooAuto in the end of March 2008. The charter capital of new venture is US$266.7 million.

General Motors owns 25% shares and plus one share in the new venture and it can increase its share up to 40%. Currently, Uzavtosanoat possesses 75% shares in GM Uzbekistan.

GM Uzbekistan produced 158,507 in January-October 2008 or increased output by 10.6% year-on-year.

The venture produced 77,959 Nexia cars (up 10.6%), 56,972 Matiz cars (up 7.6%), 19,960 Damas mini-buses (up 14.9%), 1,748 Captiva, 1,853 Epica and 15 Tacuma. The plant started production of Chevrolet models (Captiva, Epica, Tacuma) in October 2007.

Stay up to date with the latest news
Subscribe to our telegram channel